OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

OrganiGram Holdings Inc.TSX: OGI.TO

Gross Margin · Q2 FY2026 · quarter ended Mar 2026

Gross margin narrows to -15.1%

Gross margin was -15.1% in Q2 FY2026, down 43.1 pp from a year earlier. On a trailing-twelve-month basis it was -3.1%, down 35.8 pp year over year.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-15.1%-51.8 pp QoQ
Last fiscal yearSep 2025
3.7%-26.1 pp YoY
LTMMar 2026
-3.1%-35.8 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-43.1 pp——
1 year-26.1 pp——
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
3.7%
Year-over-year change
-26.1pp

Gross Margin vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • OGI.TO's LTM Mar 2026 gross margin of -3.1% is the lowest of the 9 companies compared; the peer median is 49.2%.
  • Its year-over-year change of -35.8 pp is the lowest of 9, against a peer median of -5.8 pp.
OGI.TO Competitors Peer median
Gross Margin for OGI.TO and competitors
Company Period LTM level YoY 3-year change
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 202692.2% +1.9 pp-2.8 pp
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202674.5% +2.6 pp-14.9 pp
HLS.TOHLS Therapeutics Inc.LTM Mar 202661.7% -21.3 pp-49.4 pp
TSND.TOTerrAscend Corp.LTM Mar 202650.9% -0.7 pp+0.4 pp
XLY.TOAuxly Cannabis Group Inc.LTM Mar 202647.5% -5.8 pp+39.8 pp
DR.TOMedical Facilities CorporationLTM Mar 202644.5% -21.3 pp-28.1 pp
ACB.TOAurora Cannabis Inc.LTM Mar 202631.5% -23.2 pp+32.8 pp
WEED.TOCanopy Growth CorporationLTM Mar 202623.6% -5.9 pp+54.0 pp
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-3.1% -35.8 pp—
EPRX.TOEupraxia Pharmaceuticals Inc.FY2025— ——
Peer median (excluding OGI.TO) 49.2%-5.8 pp-1.2 pp

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M259.18M
Cost of Revenue107.56M114.24M114.13M112.32M249.67M
Gross Profit(28.4M)31.57M35.07M47.52M9.51M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.52M59.21M71.68M68.14M86.88M
Operating Expenses63.42M70.32M277.81M83.2M97.82M
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
EBITDA(95.59M)10.97M(207.62M)(23.59M)(20.55M)
EBITDA Margin-120.8%7.5%-139.2%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(88.31M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M3.31M1.15M
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M9.74M(9.77M)49.78M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(38.53M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)(5.28M)(13.77M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.19)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.19)
Weighted Avg Shares64.03M77.23M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M77.23M81.29M95.29M127.67M

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.